Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleStudy of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- Where
- Boston, Fort Myers, Houston, Los Angeles, Nashville, New York, Seattle, St Louis
- Age
- 18 years to 100 years
- People
- 280 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06726148 · EU 2024-517281-42-00 - Phase 1Taking peopleA Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Where
- Austin, Boston, Denver, Fairfax, New York, San Antonio, San Diego, Sarasota, Washington D.C.
- Age
- 18 years and over
- People
- 200
- Run by
- Sutro Biopharma, Inc.
See details and how to joinNCT07227168 - No phaseTaking peopleInvestigating Hereditary Risk In Thoracic Cancers (INHERIT)
- Where
- Boston
- Age
- 18 years and over
- People
- 500
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT05587439 - Phase 3Taking peoplePhase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Where
- Bethesda, Bridgeton, Brooklyn, Chicago, Dallas, Detroit, Fairfax, Fort Belvoir, Fort Wayne, Fountain Valley, Hinsdale, Honolulu, Houston, Jacksonville, Las Vegas, Los Alamitos, Los Angeles, Midlothian, Milwaukee, New Haven, New York, North Chicago, Ocala, Orange, Orange City, Saint Paul, San Diego, Santa Monica, Seattle, St Louis, Tacoma, Walnut Creek, Washington D.C., Webster, Woodway
- Age
- 18 years and over
- People
- 582 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06350097 · EU 2023-509883-89-00 - Phase 1/2Taking peopleA Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- Where
- Aurora, Belleville, Beverly Hills, Cleveland, Dallas, Fairfax, Hackensack, Houston, Iowa City, Jacksonville, Los Angeles, New York, Phoenix, Rochester, Santa Monica, Tyler
- Age
- 18 years and over
- People
- 594 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06892548 · EU 2024-520238-31-01 - Phase 2Not yet taking people in United StatesTesting the SurVaxM Vaccine for Lung Cancer Prevention
- Where
- Aurora, Buffalo, Chicago, Knoxville
- Age
- 18 years and over
- People
- 80
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07169617 - No phaseNot yet taking people in United StatesCombination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1
- Where
- Dallas
- Age
- 18 years and over
- People
- 300
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07254650 - Phase 3Taking peopleThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anaheim, Anchorage, Ann Arbor, Arroyo Grande, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bellevue, Bellflower, Bethesda, Birmingham, Boise, Boston, Brooklyn, Burlington, Carson City, Chapel Hill, Charleston, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Falls Church, Fargo, Fontana, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Hartford, Henderson, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Madera, Madison, Marshfield, Maywood, Memphis, Mesa, Miami, Milwaukee, Minneapolis, Morgantown, Morristown, Muskegon, Nashville, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Niles, Norfolk, Norton Shores, Oakland, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Paterson, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reed City, Reno, Renton, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Scarborough, Seattle, Sioux Falls, Spokane, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Traverse City, Tucson, Valhalla, Washington D.C., Wilmington, Winfield, Winston-Salem, Wyoming, Yakima
- Age
- Up to 50 years
- People
- 62 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05235165 - No phaseTaking peopleHealth Education Approach to Lung Screening
- Where
- Carrboro, Charleston, Richmond
- Age
- 50 years to 80 years
- People
- 675
- Run by
- Virginia Commonwealth University
See details and how to joinNCT06070870 - No phaseTaking peoplePractical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
- Where
- Boston
- Age
- 65 years and over
- People
- 64
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT06987890 - Phase 2Taking peopleRisk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer
- Where
- Chico, Marysville, Sacramento, Truckee
- Age
- 18 years and over
- People
- 56
- Run by
- University of California, Davis
See details and how to joinNCT07250477 - No phaseTaking peopleLEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
- Where
- Boston
- Age
- 18 years and over
- People
- 2,250
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07600801 - Phase 1Taking peopleStudy of NXP900 With Lorlatinib in ALK+ Lung Cancer
- Where
- Fairfax
- People
- 54
- Run by
- Nuvectis Pharma, Inc.
See details and how to joinNCT07784959 - No phaseTaking peoplePre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- Where
- Aurora, Highlands Ranch
- Age
- 18 years to 99 years
- People
- 200
- Run by
- University of Colorado, Denver
See details and how to joinNCT05517811 - Phase 1/2Taking peoplePulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- Where
- Buffalo
- Age
- 18 years and over
- People
- 99
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT03965234 - Phase 1Taking peopleStudy of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
- Where
- Fairfax, Goodyear, Memphis, New York, Saint Paul, Tampa, Zion
- Age
- 18 years to 99 years
- People
- 160 worldwide
- Run by
- Amgen
See details and how to joinNCT07531095 · EU 2025-522888-15-00 - No phaseTaking peopleCollecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- Where
- Nashville
- Age
- 18 years to 120 years
- People
- 4,000
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT00897117 - No phaseTaking peoplePatient-Derived Xenografts to Reduce Cancer Health Disparities
- Where
- Orange, Sacramento
- Age
- 21 years to 100 years
- People
- 500
- Run by
- University of California, Davis
See details and how to joinNCT04410302 - Phase 2Taking peopleBrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
- Where
- Providence
- Age
- 18 years and over
- People
- 25
- Run by
- Brown University
See details and how to joinNCT04933903 - Phase 1/2Taking peoplePersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Where
- Jacksonville
- Age
- 16 years and over
- People
- 138
- Run by
- Mayo Clinic
See details and how to joinNCT05269381 - No phaseTaking peopleA Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 100
- Run by
- Mayo Clinic
See details and how to joinNCT06122064 - No phaseTaking peopleDosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Where
- Milwaukee
- Age
- 65 years and over
- People
- 50
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07227077 - No phaseTaking peopleUnderstanding New Cachexia Subtypes Through Observational Epidemiological Research
- Where
- Pleasanton
- Age
- 18 years and over
- People
- 800
- Run by
- Kaiser Permanente
See details and how to joinNCT07776353 - Phase 1/2TerminatedStudy of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- Where
- Boston, Detroit, Grand Rapids, Houston, Nashville, New York, Orange, Stanford
- Age
- 18 years and over
- People
- 244 worldwide
- Run by
- Taiho Pharmaceutical Co., Ltd.
See details and how to joinNCT04683250 - No phaseTaking peopleImpact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- Where
- Columbus, Houston, La Jolla, New York, Philadelphia, Seattle, St Louis, Tampa, The Bronx, Washington D.C.
- Age
- 45 years to 80 years
- People
- 100
- Run by
- AIDS Malignancy Consortium
See details and how to joinNCT04949464